The Academy of Managed Care Pharmacy (AMCP) will be hosting a new conference, Nexus 2013, October 15-18 in San Antonio, Texas. Nexus 2013 will aim to simplify the complex healthcare system and find new and innovative solutions by bringing together people from both sides of the equation. The new conference will be replacing AMCP’s Education Conference.
The Academy of Managed Care Pharmacy (AMCP) will be hosting a new conference, Nexus 2013, October 15-18 in San Antonio, Texas. Nexus 2013 will aim to simplify the complex healthcare system and find new and innovative solutions by bringing together people from both sides of the equation. The new conference will be replacing AMCP’s Education Conference.
Attendees will have the opportunity to attend 2 “Innovative Interchange Sessions,” and in-depth 3 hour sessions, which are new to the conference, will provide information about healthcare reform and solutions to the challenges of chronic diseases. Those interested in the drug pipeline can attend 2 sessions: Specialty Pharmaceuticals in Development or Brand and Generic Drug in Development.
Nexus 2013 will feature 4 program tracks: specialty pharmacy, healthcare reform, clinical breakthroughs, and research in managed care. Each track will feature a number of informative sessions and the Healthcare Reform track will feature a Spotlight Session. According to AMCP, the education sessions will have more opportunities for active learning and audience interaction than previous education conferences.
Pharmacy students will have the option to attend 2 special sessions, both developed especially for students, at the conference. Residents will have a chance to participate in a Managed Care Pharmacy Residency Showcase.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More